AUA Capital Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,500
Closed -$1K 376
2020
Q4
$1K Hold
1,500
﹤0.01% 342
2020
Q3
$3K Buy
+1,500
New +$4.28K ﹤0.01% 224

Other funds holding BMY.RT

AUA Capital Management's BMY.RT Position: Q1 2021 in Review

AUA Capital Management sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 1,500 shares — an estimated $1K sold.

AUA Capital Management first reported a position in BMY.RT in Q3 2020 and held it in 2 quarters. The position peaked at $3K in Q3 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • AUA Capital Management reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • AUA Capital Management sold 1,500 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $1K.
  • AUA Capital Management first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q3 2020 and held it in 2 quarters.
  • AUA Capital Management's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $3K in Q3 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on AUA Capital Management's 13F filing for Q1 2021, filed 5 May 2021.